NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,825 | -1.1% | 67 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $6,904 | +0.5% | 67 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $6,872 | +13.1% | 67 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $6,078 | +21.6% | 67 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $5,000 | -16.7% | 67 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $6,000 | 0.0% | 67 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $6,000 | +100.0% | 67 | +67.5% | 0.00% | 0.0% |
| Q4 2018 | $3,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $3,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $3,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $3,000 | -66.7% | 40 | -60.0% | 0.00% | -66.7% |
| Q4 2017 | $9,000 | -79.1% | 100 | -80.0% | 0.01% | -79.3% |
| Q3 2017 | $43,000 | +2.4% | 500 | 0.0% | 0.03% | +3.6% |
| Q2 2017 | $42,000 | +90.9% | 500 | +66.7% | 0.03% | +75.0% |
| Q1 2017 | $22,000 | 0.0% | 300 | 0.0% | 0.02% | 0.0% |
| Q4 2016 | $22,000 | – | 300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |